Terns Pharmaceuticals Inc (TERN)

$5.27 +0.22 (4.36%)
Market Cap 441.05M
Revenue (ttm) 0.00
Net Income (ttm) -88.85M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 830,300
Avg Vol 837,066
Day's Range N/A - N/A
Shares Out 87.34M
Stochastic %K 99%
Beta -0.11
Analysts Strong Sell
Price Target $20.17

Company Profile

Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in Phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 525 5535
Fax: 650 275 4254
Address:
1065 East Hillsdale Boulevard, Suite 100, Foster City, United States
GoldmanSlaps
GoldmanSlaps Jul. 17 at 1:48 AM
$TERN such a quiet board thats usually a good sign lol
1 · Reply
Bulltrader988
Bulltrader988 Jul. 17 at 1:25 AM
$TERN ...👃👀
0 · Reply
RonIsWrong
RonIsWrong Jul. 17 at 1:19 AM
$TERN uptrend continues
0 · Reply
Mkm950
Mkm950 Jul. 16 at 1:38 PM
$TERN hidden gem💎
0 · Reply
jeroen2505
jeroen2505 Jul. 15 at 5:53 PM
$TERN buying dips below 5
0 · Reply
Bulltrader988
Bulltrader988 Jul. 15 at 6:04 AM
$TERN ... Im sniffing $8 👃👀
0 · Reply
ekfpromo
ekfpromo Jul. 14 at 11:21 PM
$TERN I am loving the rise, I just wish I knew what was going on. There’s no news.
1 · Reply
ekfpromo
ekfpromo Jul. 14 at 3:23 PM
$TERN does anyone think we may get bought out by end of year?
1 · Reply
RonIsWrong
RonIsWrong Jul. 14 at 3:04 PM
$TERN behaving well
0 · Reply
gnarled15
gnarled15 Jul. 14 at 3:02 PM
$TERN nice to see this back above $5
1 · Reply
Latest News on TERN
Terns Pharmaceuticals: A Risky Buy Ahead Of Q4 Obesity, Oncology Catalysts

Jul 11, 2025, 11:27 AM EDT - 5 days ago

Terns Pharmaceuticals: A Risky Buy Ahead Of Q4 Obesity, Oncology Catalysts

Terns Pharmaceuticals Presents Positive Data from Phase 1 Study of TERN-601 Once-daily Oral GLP-1R Agonist for Treatment of Obesity at 85th Annual American Diabetes Association Scientific Sessions

Jun 23, 2025, 4:07 PM EDT - 23 days ago

Terns Pharmaceuticals Presents Positive Data from Phase 1 Study of TERN-601 Once-daily Oral GLP-1R Agonist for Treatment of Obesity at 85th Annual American Diabetes Association Scientific Sessions

Terns Pharmaceuticals to Participate in Upcoming June Investor Conferences

May 29, 2025, 4:05 PM EDT - 6 weeks ago

Terns Pharmaceuticals to Participate in Upcoming June Investor Conferences

Terns Pharmaceuticals Selected for Oral Presentation at European Hematology Association Congress For Preclinical Data on Novel Allosteric BCR-ABL Inhibitor TERN-701

May 14, 2025, 9:30 AM EDT - 2 months ago

Terns Pharmaceuticals Selected for Oral Presentation at European Hematology Association Congress For Preclinical Data on Novel Allosteric BCR-ABL Inhibitor TERN-701

Terns Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Updates

May 8, 2025, 4:05 PM EDT - 2 months ago

Terns Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Updates

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

May 2, 2025, 4:05 PM EDT - 2 months ago

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

Terns Pharmaceuticals to Participate in The Citizens Life Sciences Conference

Apr 30, 2025, 4:05 PM EDT - 2 months ago

Terns Pharmaceuticals to Participate in The Citizens Life Sciences Conference

Terns Pharmaceuticals Reports Inducement Grant to New Employees Under Nasdaq Listing Rule 5635(C)(4)

Apr 2, 2025, 4:05 PM EDT - 3 months ago

Terns Pharmaceuticals Reports Inducement Grant to New Employees Under Nasdaq Listing Rule 5635(C)(4)

Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates

Mar 20, 2025, 4:05 PM EDT - 4 months ago

Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates

Terns Pharmaceuticals Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(C)(4)

Feb 26, 2025, 4:05 PM EST - 5 months ago

Terns Pharmaceuticals Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(C)(4)

Terns Pharmaceuticals Provides Program Updates and Announces Participation at TD Cowen 45th Annual Healthcare Conference

Feb 25, 2025, 8:05 AM EST - 5 months ago

Terns Pharmaceuticals Provides Program Updates and Announces Participation at TD Cowen 45th Annual Healthcare Conference

Terns Pharmaceuticals Appoints Andrew Gengos as Chief Financial Officer

Feb 24, 2025, 4:05 PM EST - 5 months ago

Terns Pharmaceuticals Appoints Andrew Gengos as Chief Financial Officer

Terns Pharmaceuticals Appoints Robert Azelby to Board of Directors

Feb 20, 2025, 4:05 PM EST - 5 months ago

Terns Pharmaceuticals Appoints Robert Azelby to Board of Directors

Terns Pharmaceuticals to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Feb 5, 2025, 4:05 PM EST - 5 months ago

Terns Pharmaceuticals to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

Feb 3, 2025, 4:05 PM EST - 5 months ago

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

Terns Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference

Jan 8, 2025, 4:05 PM EST - 6 months ago

Terns Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference

Terns's stock soars as analysts cheer leukemia data — and predict more gains

Dec 4, 2024, 1:18 PM EST - 8 months ago

Terns's stock soars as analysts cheer leukemia data — and predict more gains

Terns Pharma broadens beyond obesity drugs with upbeat data in leukemia trial

Dec 3, 2024, 8:01 AM EST - 8 months ago

Terns Pharma broadens beyond obesity drugs with upbeat data in leukemia trial

Top 3 Health Care Stocks You'll Regret Missing In Q4

Nov 19, 2024, 7:52 AM EST - 8 months ago

Top 3 Health Care Stocks You'll Regret Missing In Q4

AMRN SLN

Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of Directors

Nov 18, 2024, 4:05 PM EST - 8 months ago

Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of Directors

RFK Jr. is not a fan of weight-loss drugs or vaccines. Stocks are tanking.

Nov 15, 2024, 11:19 AM EST - 8 months ago

RFK Jr. is not a fan of weight-loss drugs or vaccines. Stocks are tanking.

AMGN LLY NVO VKTX

Terns Pharmaceuticals: Obesity Advancement Continues With Other Q1 2025 Program Catalyst

Sep 25, 2024, 10:30 AM EDT - 10 months ago

Terns Pharmaceuticals: Obesity Advancement Continues With Other Q1 2025 Program Catalyst

Undercovered Stock Picks From September 6-12: Lithium, Uranium, Gold, & Plastic

Sep 13, 2024, 1:30 PM EDT - 10 months ago

Undercovered Stock Picks From September 6-12: Lithium, Uranium, Gold, & Plastic

ATLX BRZE DOCN EGO PL SLVM SMR

Terns Announces Closing of Public Offering of Shares of Common Stock and Pre-Funded Warrants, Including Full Exercise of Underwriters' Option to Purchase Additional Shares

Sep 12, 2024, 7:00 PM EDT - 10 months ago

Terns Announces Closing of Public Offering of Shares of Common Stock and Pre-Funded Warrants, Including Full Exercise of Underwriters' Option to Purchase Additional Shares

Terns Announces Pricing of Upsized $150.15 Million Public Offering

Sep 10, 2024, 10:50 PM EDT - 11 months ago

Terns Announces Pricing of Upsized $150.15 Million Public Offering

Terns Pharmaceuticals: Weight Loss Drug TERN-601 Is Competitive

Sep 10, 2024, 10:25 AM EDT - 11 months ago

Terns Pharmaceuticals: Weight Loss Drug TERN-601 Is Competitive

Terns Announces Proposed Public Offering

Sep 9, 2024, 4:01 PM EDT - 11 months ago

Terns Announces Proposed Public Offering

Terns Pharmaceuticals Stock Is Soaring on Good Data for Weight-Loss Pill

Sep 9, 2024, 9:58 AM EDT - 11 months ago

Terns Pharmaceuticals Stock Is Soaring on Good Data for Weight-Loss Pill

Top 2 Health Care Stocks That May Collapse This Quarter

Sep 9, 2024, 9:12 AM EDT - 11 months ago

Top 2 Health Care Stocks That May Collapse This Quarter

IMVT

Terns Pharmaceuticals' stock soars 30% after biotech posts positive results in trial of weight-loss drug in pill form

Sep 9, 2024, 7:48 AM EDT - 11 months ago

Terns Pharmaceuticals' stock soars 30% after biotech posts positive results in trial of weight-loss drug in pill form

Terns Pharmaceuticals' oral obesity drug cuts weight by 4.9% in early study

Sep 9, 2024, 7:34 AM EDT - 11 months ago

Terns Pharmaceuticals' oral obesity drug cuts weight by 4.9% in early study

Terns Pharmaceuticals Announces Positive Phase 1 Clinical Trial Results with TERN-601 Once-Daily Oral GLP-1R Agonist for the Treatment of Obesity

Sep 9, 2024, 7:05 AM EDT - 11 months ago

Terns Pharmaceuticals Announces Positive Phase 1 Clinical Trial Results with TERN-601 Once-Daily Oral GLP-1R Agonist for the Treatment of Obesity

Terns Pharmaceuticals Appoints Biotech Executive Elona Kogan as Chief Legal Officer and Announces Upcoming CFO Transition

Jul 29, 2024, 4:05 PM EDT - 1 year ago

Terns Pharmaceuticals Appoints Biotech Executive Elona Kogan as Chief Legal Officer and Announces Upcoming CFO Transition

Terns Pharmaceuticals Highlights New Preclinical Data Supporting TERN-501 in Combination with a GLP-1R Agonist for Obesity at the ADA's 84th Annual Scientific Sessions and Upcoming Conference Participation

Jun 21, 2024, 6:30 PM EDT - 1 year ago

Terns Pharmaceuticals Highlights New Preclinical Data Supporting TERN-501 in Combination with a GLP-1R Agonist for Obesity at the ADA's 84th Annual Scientific Sessions and Upcoming Conference Participation

Terns Pharmaceuticals to Participate in UBS Obesity Therapeutics Day

May 17, 2024, 4:05 PM EDT - 1 year ago

Terns Pharmaceuticals to Participate in UBS Obesity Therapeutics Day

Mizuho still recommends Terns Pharma as a cheap entry to the weight-loss-drug craze

May 15, 2024, 12:33 PM EDT - 1 year ago

Mizuho still recommends Terns Pharma as a cheap entry to the weight-loss-drug craze

Terns Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Updates

May 13, 2024, 8:05 AM EDT - 1 year ago

Terns Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Updates

Terns Pharmaceuticals Announces Leadership Changes

May 8, 2024, 4:05 PM EDT - 1 year ago

Terns Pharmaceuticals Announces Leadership Changes

Terns Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference 2024

May 7, 2024, 4:05 PM EDT - 1 year ago

Terns Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference 2024

Terns Pharmaceuticals Announces Data from Ongoing Phase 1 Pharmacokinetic Study of Allosteric BCR-ABL Inhibitor TERN-701 in Adult Healthy Volunteers and Highlights Potential for Competitive Differentiation

Apr 29, 2024, 4:05 PM EDT - 1 year ago

Terns Pharmaceuticals Announces Data from Ongoing Phase 1 Pharmacokinetic Study of Allosteric BCR-ABL Inhibitor TERN-701 in Adult Healthy Volunteers and Highlights Potential for Competitive Differentiation

Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business Officer

Apr 10, 2024, 4:05 PM EDT - 1 year ago

Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business Officer

This small-cap stock is expected to take off — if its weight-loss pill trial succeeds

Mar 28, 2024, 3:02 PM EDT - 1 year ago

This small-cap stock is expected to take off — if its weight-loss pill trial succeeds

Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates

Mar 14, 2024, 4:05 PM EDT - 1 year ago

Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates

Terns Pharmaceuticals Announces Orphan Drug Designation Granted to TERN-701 for the Treatment of Chronic Myeloid Leukemia

Mar 11, 2024, 4:05 PM EDT - 1 year ago

Terns Pharmaceuticals Announces Orphan Drug Designation Granted to TERN-701 for the Treatment of Chronic Myeloid Leukemia

Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences

Feb 27, 2024, 4:05 PM EST - 1 year ago

Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences

Terns Pharmaceuticals Reports Inducement Grants to New Chief Executive Officer Under Nasdaq Listing Rule 5635(C)(4)

Feb 7, 2024, 4:05 PM EST - 1 year ago

Terns Pharmaceuticals Reports Inducement Grants to New Chief Executive Officer Under Nasdaq Listing Rule 5635(C)(4)

Terns Pharmaceuticals Appoints Amy Burroughs as Chief Executive Officer

Feb 7, 2024, 8:05 AM EST - 1 year ago

Terns Pharmaceuticals Appoints Amy Burroughs as Chief Executive Officer

The weight loss drug market may soon get more crowded – here are the companies trying to enter the booming space

Jan 17, 2024, 3:40 PM EST - 1 year ago

The weight loss drug market may soon get more crowded – here are the companies trying to enter the booming space

VKTX GPCR

Terns Pharmaceuticals to Highlight 2024 Priorities and Clinical Milestones at the 42nd Annual J.P. Morgan Healthcare Conference

Jan 4, 2024, 4:05 PM EST - 1 year ago

Terns Pharmaceuticals to Highlight 2024 Priorities and Clinical Milestones at the 42nd Annual J.P. Morgan Healthcare Conference

Terns Pharmaceuticals to Present at the JMP Securities Hematology and Oncology Summit

Nov 29, 2023, 4:05 PM EST - 1 year ago

Terns Pharmaceuticals to Present at the JMP Securities Hematology and Oncology Summit

GoldmanSlaps
GoldmanSlaps Jul. 17 at 1:48 AM
$TERN such a quiet board thats usually a good sign lol
1 · Reply
Bulltrader988
Bulltrader988 Jul. 17 at 1:25 AM
$TERN ...👃👀
0 · Reply
RonIsWrong
RonIsWrong Jul. 17 at 1:19 AM
$TERN uptrend continues
0 · Reply
Mkm950
Mkm950 Jul. 16 at 1:38 PM
$TERN hidden gem💎
0 · Reply
jeroen2505
jeroen2505 Jul. 15 at 5:53 PM
$TERN buying dips below 5
0 · Reply
Bulltrader988
Bulltrader988 Jul. 15 at 6:04 AM
$TERN ... Im sniffing $8 👃👀
0 · Reply
ekfpromo
ekfpromo Jul. 14 at 11:21 PM
$TERN I am loving the rise, I just wish I knew what was going on. There’s no news.
1 · Reply
ekfpromo
ekfpromo Jul. 14 at 3:23 PM
$TERN does anyone think we may get bought out by end of year?
1 · Reply
RonIsWrong
RonIsWrong Jul. 14 at 3:04 PM
$TERN behaving well
0 · Reply
gnarled15
gnarled15 Jul. 14 at 3:02 PM
$TERN nice to see this back above $5
1 · Reply
keokeostwiz
keokeostwiz Jul. 14 at 2:45 PM
$TERN Time for institutional buying to ramp up participation exposure and provide lift off....JMO
0 · Reply
Foreverbagholding
Foreverbagholding Jul. 14 at 2:34 PM
$TERN 🥳
0 · Reply
Bulltrader988
Bulltrader988 Jul. 11 at 7:15 PM
$TERN and after $5 .... 👃👀
0 · Reply
fatcoin888
fatcoin888 Jul. 10 at 10:39 PM
$TERN initiated with 'Early-Stage Biotech' at Goldman Sachs
3 · Reply
Foreverbagholding
Foreverbagholding Jul. 10 at 5:13 PM
$TERN over 5 next week?
0 · Reply
DonCorleone77
DonCorleone77 Jul. 9 at 7:29 PM
$TERN Okay, I bought this stock about a week ago and am up around 33%. Can someone guess what I did just now?
4 · Reply
RonIsWrong
RonIsWrong Jul. 9 at 1:47 PM
$TERN terning
0 · Reply
DonCorleone77
DonCorleone77 Jul. 9 at 12:26 PM
$TERN Information regarding Mizho analyst note on TERN issued today: https://x.com/CorleoneDon77/status/1942923154382348451
0 · Reply
thegreenzone
thegreenzone Jul. 8 at 11:03 PM
$ALT vs $TERN race to 10 is on
2 · Reply
RunnerSignals
RunnerSignals Jul. 8 at 9:17 PM
$TERN $BTE $CIVI $WTTR $PTEN warriors bounce back opened red but flipped green like champs today
0 · Reply
RonIsWrong
RonIsWrong Jul. 8 at 7:17 PM
$TERN looking good
0 · Reply
BIOTECH_GURU
BIOTECH_GURU Jul. 8 at 7:16 PM
$TERN 🔥🔥
0 · Reply